))
Challenges and Opportunities in AI Implementation
Manage episode 486882822 series 3643376
Content provided by Keith Parent. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Keith Parent or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode of Driving the Business of Science, Keith Parent, CEO of Court Square Group, talks with Catherine Lunardi, CEO of GENAIZ, about the challenges and opportunities of implementing Artificial Intelligence (AI) in life science companies. Catherine explains her company's Intelligent Automation solutions, particularly their data orchestration platform. They discuss their partnership, which began at an economic development forum in Massachusetts. Catherine shares her background in pharmaceuticals and the inspiration behind GENAIZ, emphasizing the importance of AI in streamlining data management. They highlight successful projects involving a cross-referencing tool for large document volumes and introduce GENAIZ's semantic search engine for literature reviews.
GENAIZ offers a powerful Data Orchestration platform purpose-built for the life sciences industry. We empower Pharmaceutical Sponsors, CDMO’s, CROs, Hospitals, Clinical Trials, and Academic Labs to make their data “talk” fast using advanced, Intelligent Automation solutions. Our Intelligent Automated solutions break down silos across Regulatory, Quality, Laboratory, and R&D functions—streamlining processes, enhancing compliance, and accelerating decision-making.
9 episodes
Share
